Výsledky vyhľadávania - "Survival Rate [MeSH]"

Steroid Withdrawal Versus Maintenance in Simultaneous Pancreas–Kidney Transplantation: Long‐Term Outcomes in a Single‐Center Retrospective Cohort

Autori: Meier, Raphael PH Abbasi, Ali B Gamino, Gerardo a ďalší

Zdroj: Clinical Transplantation. 39(11)

Predmety: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), Kidney Disease (rcdc), Organ Transplantation (rcdc), Transplantation (rcdc), 6.1 Pharmaceuticals (hrcs-rac), Renal and urogenital (hrcs-hc), Humans (mesh), Pancreas Transplantation (mesh), Kidney Transplantation (mesh), Retrospective Studies (mesh), Female (mesh), Male (mesh), Graft Rejection (mesh), Graft Survival (mesh), Follow-Up Studies (mesh), Prognosis (mesh), Immunosuppressive Agents (mesh), Middle Aged (mesh), Adult (mesh), Risk Factors (mesh), Survival Rate (mesh), Kidney Function Tests (mesh), Steroids (mesh), Postoperative Complications (mesh), body mass index, diabetes, end-stage renal disease, immunosuppression, outcomes, simultaneous pancreas and kidney transplantation, steroids, Humans (mesh), Postoperative Complications (mesh), Steroids (mesh), Immunosuppressive Agents (mesh), Kidney Function Tests (mesh), Prognosis (mesh), Kidney Transplantation (mesh), Pancreas Transplantation (mesh), Survival Rate (mesh), Risk Factors (mesh), Retrospective Studies (mesh), Follow-Up Studies (mesh), Graft Rejection (mesh), Graft Survival (mesh), Adult (mesh), Middle Aged (mesh), Female (mesh), Male (mesh), body mass index, diabetes, end‐stage renal disease, immunosuppression, outcomes, simultaneous pancreas and kidney transplantation, steroids, Humans (mesh), Pancreas Transplantation (mesh), Kidney Transplantation (mesh), Retrospective Studies (mesh), Female (mesh), Male (mesh), Graft Rejection (mesh), Graft Survival (mesh), Follow-Up Studies (mesh), Prognosis (mesh), Immunosuppressive Agents (mesh), Middle Aged (mesh), Adult (mesh), Risk Factors (mesh), Survival Rate (mesh), Kidney Function Tests (mesh), Steroids (mesh), Postoperative Complications (mesh), 1103 Clinical Sciences (for), Surgery (science-metrix), 3202 Clinical sciences (for-2020)

Popis súboru: application/pdf

Prístupová URL adresa: https://escholarship.org/uc/item/6w15j0hh
https://escholarship.org/content/qt6w15j0hh/qt6w15j0hh.pdf

Survivorship in advanced ovarian cancer: a prognostic model for overall survival and risk of recurrence

Autori: Shachar, Eliya Raz, Yael Rotkop, Gilat a ďalší

Zdroj: The Oncologist. 30(9)

Predmety: 32 Biomedical and Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Cancer (rcdc), Clinical Research (rcdc), Women's Health (rcdc), Ovarian Cancer (rcdc), Rare Diseases (rcdc), 4.2 Evaluation of markers and technologies (hrcs-rac), 2.4 Surveillance and distribution (hrcs-rac), Cancer (hrcs-hc), 3 Good Health and Well Being (sdg), Humans (mesh), Female (mesh), Middle Aged (mesh), Prognosis (mesh), Retrospective Studies (mesh), Ovarian Neoplasms (mesh), Neoplasm Recurrence, Local (mesh), Aged (mesh), Adult (mesh), Carcinoma, Ovarian Epithelial (mesh), Cancer Survivors (mesh), Survival Rate (mesh), ovarian cancer, long-term survivors, prognostic model, optimal debulking, BRCA, overall survival, risk of recurrence, platinum sensitivity, homologous recombination deficiency, Humans (mesh), Ovarian Neoplasms (mesh), Neoplasm Recurrence, Local (mesh), Prognosis (mesh), Survival Rate (mesh), Retrospective Studies (mesh), Adult (mesh), Aged (mesh), Middle Aged (mesh), Female (mesh), Cancer Survivors (mesh), Carcinoma, Ovarian Epithelial (mesh), BRCA, homologous recombination deficiency, long-term survivors, optimal debulking, ovarian cancer, overall survival, platinum sensitivity, prognostic model, risk of recurrence, Humans (mesh), Female (mesh), Middle Aged (mesh), Prognosis (mesh), Retrospective Studies (mesh), Ovarian Neoplasms (mesh), Neoplasm Recurrence, Local (mesh), Aged (mesh), Adult (mesh), Carcinoma, Ovarian Epithelial (mesh), Cancer Survivors (mesh), Survival Rate (mesh), 1112 Oncology and Carcinogenesis (for), Oncology & Carcinogenesis (science-metrix), 3211 Oncology and carcinogenesis (for-2020)

Popis súboru: application/pdf

Prístupová URL adresa: https://escholarship.org/uc/item/3nk6r4hm
https://escholarship.org/content/qt3nk6r4hm/qt3nk6r4hm.pdf

Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responses

Autori: Lucas, Calixto-Hope G Al-Adli, Nadeem N Young, Jacob S a ďalší

Zdroj: Neuro-Oncology. 27(1)

Predmety: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Genetics (rcdc), Orphan Drug (rcdc), Rare Diseases (rcdc), Neurosciences (rcdc), Brain Disorders (rcdc), Cancer (rcdc), Cancer Genomics (rcdc), Brain Cancer (rcdc), Human Genome (rcdc), 2.1 Biological and endogenous factors (hrcs-rac), Cancer (hrcs-hc), Humans (mesh), Glioblastoma (mesh), Brain Neoplasms (mesh), Isocitrate Dehydrogenase (mesh), Female (mesh), Male (mesh), Middle Aged (mesh), DNA Methylation (mesh), Mutation (mesh), Prognosis (mesh), Adult (mesh), Phenotype (mesh), Aged (mesh), Neoplasm Recurrence, Local (mesh), Biomarkers, Tumor (mesh), Survival Rate (mesh), Follow-Up Studies (mesh), Promoter Regions, Genetic (mesh), Epigenesis, Genetic (mesh), DNA methylation, glioblastoma, gliosarcoma, molecular neuropathology, temozolomide-induced hypermutation, Humans (mesh), Glioblastoma (mesh), Brain Neoplasms (mesh), Neoplasm Recurrence, Local (mesh), Isocitrate Dehydrogenase (mesh), Prognosis (mesh), Survival Rate (mesh), Follow-Up Studies (mesh), DNA Methylation (mesh), Epigenesis, Genetic (mesh), Phenotype (mesh), Mutation (mesh), Adult (mesh), Aged (mesh), Middle Aged (mesh), Female (mesh), Male (mesh), Promoter Regions, Genetic (mesh), Biomarkers, Tumor (mesh), DNA methylation, glioblastoma, gliosarcoma, molecular neuropathology, temozolomide-induced hypermutation, Humans (mesh), Glioblastoma (mesh), Brain Neoplasms (mesh), Isocitrate Dehydrogenase (mesh), Female (mesh), Male (mesh), Middle Aged (mesh), DNA Methylation (mesh), Mutation (mesh), Prognosis (mesh), Adult (mesh), Phenotype (mesh), Aged (mesh), Neoplasm Recurrence, Local (mesh), Biomarkers, Tumor (mesh), Survival Rate (mesh), Follow-Up Studies (mesh), Promoter Regions, Genetic (mesh), Epigenesis, Genetic (mesh), 1109 Neurosciences (for), 1112 Oncology and Carcinogenesis (for), Oncology & Carcinogenesis (science-metrix), 3211 Oncology and carcinogenesis (for-2020)

Popis súboru: application/pdf

Prístupová URL adresa: https://escholarship.org/uc/item/0gg6p5rb
https://escholarship.org/content/qt0gg6p5rb/qt0gg6p5rb.pdf

Intensification of upfront chemotherapy for patients with myeloid blast phase CML: a single center experience

Autori: Lee, Benjamin J Griffin, Shawn P Doh, Jean a ďalší

Zdroj: Annals of Hematology. 103(12)

Predmety: 32 Biomedical and Clinical Sciences (for-2020), 3201 Cardiovascular Medicine and Haematology (for-2020), 3202 Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Cancer (rcdc), Hematology (rcdc), Rare Diseases (rcdc), Clinical Research (rcdc), Orphan Drug (rcdc), 6.1 Pharmaceuticals (hrcs-rac), Cancer (hrcs-hc), Humans (mesh), Male (mesh), Female (mesh), Middle Aged (mesh), Adult (mesh), Retrospective Studies (mesh), Antineoplastic Combined Chemotherapy Protocols (mesh), Blast Crisis (mesh), Aged (mesh), Cytarabine (mesh), Leukemia, Myelogenous, Chronic, BCR-ABL Positive (mesh), Protein Kinase Inhibitors (mesh), Anthracyclines (mesh), Treatment Outcome (mesh), Disease-Free Survival (mesh), Survival Rate (mesh), Chronic myeloid leukemia, Blast-phase CML, Tyrosine kinase inhibitor, Myeloid blast crisis, "7+3" chemotherapy, Humans (mesh), Blast Crisis (mesh), Anthracyclines (mesh), Cytarabine (mesh), Antineoplastic Combined Chemotherapy Protocols (mesh), Protein Kinase Inhibitors (mesh), Disease-Free Survival (mesh), Treatment Outcome (mesh), Survival Rate (mesh), Retrospective Studies (mesh), Adult (mesh), Aged (mesh), Middle Aged (mesh), Female (mesh), Male (mesh), Leukemia, Myelogenous, Chronic, BCR-ABL Positive (mesh), Blast-phase CML, Chronic myeloid leukemia, Myeloid blast crisis, Tyrosine kinase inhibitor, “7 + 3” chemotherapy, Humans (mesh), Male (mesh), Female (mesh), Middle Aged (mesh), Adult (mesh), Retrospective Studies (mesh), Antineoplastic Combined Chemotherapy Protocols (mesh), Blast Crisis (mesh), Aged (mesh), Cytarabine (mesh), Leukemia, Myelogenous, Chronic, BCR-ABL Positive (mesh), Protein Kinase Inhibitors (mesh), Anthracyclines (mesh), Treatment Outcome (mesh), Disease-Free Survival (mesh), Survival Rate (mesh), 1102 Cardiorespiratory Medicine and Haematology (for), Immunology (science-metrix), 3201 Cardiovascular medicine and haematology (for-2020)

Popis súboru: application/pdf

Prístupová URL adresa: https://escholarship.org/uc/item/8ws8s27j
https://escholarship.org/content/qt8ws8s27j/qt8ws8s27j.pdf

Disparities in the Occurrence of Long-Term Effects of Bone Marrow Suppression after Treatment in Adolescent Young Adult Breast Cancer Survivors

Autori: Bellini, A Keegan, THM Li, Q a ďalší

Zdroj: Annals of Surgical Oncology. 31(11)

Predmety: 32 Biomedical and Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Infectious Diseases (rcdc), Cancer (rcdc), Women's Health (rcdc), Breast Cancer (rcdc), Minority Health (rcdc), Hematology (rcdc), Health Disparities (rcdc), Sepsis (rcdc), Pediatric (rcdc), Clinical Research (rcdc), Pediatric Cancer (rcdc), Rare Diseases (rcdc), Cancer (hrcs-hc), Humans (mesh), Female (mesh), Adolescent (mesh), Young Adult (mesh), Breast Neoplasms (mesh), Adult (mesh), Cancer Survivors (mesh), Follow-Up Studies (mesh), Prognosis (mesh), Survival Rate (mesh), Anemia (mesh), Sepsis (mesh), Incidence (mesh), California (mesh), Bone Marrow Diseases (mesh), Thrombocytopenia (mesh), Breast cancer, Adolescent and young adult (AYA), Bone marrow suppression, Race/ethnicity, AYA breast cancer survivors, Humans (mesh), Sepsis (mesh), Breast Neoplasms (mesh), Anemia (mesh), Thrombocytopenia (mesh), Bone Marrow Diseases (mesh), Prognosis (mesh), Incidence (mesh), Survival Rate (mesh), Follow-Up Studies (mesh), Adolescent (mesh), Adult (mesh), California (mesh), Female (mesh), Young Adult (mesh), Cancer Survivors (mesh), AYA breast cancer survivors, Adolescent and young adult (AYA), Bone marrow suppression, Breast cancer, Race/ethnicity, Humans (mesh), Female (mesh), Adolescent (mesh), Young Adult (mesh), Breast Neoplasms (mesh), Adult (mesh), Cancer Survivors (mesh), Follow-Up Studies (mesh), Prognosis (mesh), Survival Rate (mesh), Anemia (mesh), Sepsis (mesh), Incidence (mesh), California (mesh), Bone Marrow Diseases (mesh), Thrombocytopenia (mesh), 1112 Oncology and Carcinogenesis (for), Oncology & Carcinogenesis (science-metrix), 3211 Oncology and carcinogenesis (for-2020)

Popis súboru: application/pdf

Prístupová URL adresa: https://escholarship.org/uc/item/1zf5n454
https://escholarship.org/content/qt1zf5n454/qt1zf5n454.pdf

Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial

Autori: Roth, Patrick Gorlia, Thierry Reijneveld, Jaap C a ďalší

Zdroj: Neuro-Oncology. 26(9)

Predmety: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Cancer (rcdc), Brain Cancer (rcdc), Rare Diseases (rcdc), Patient Safety (rcdc), Radiation Oncology (rcdc), Clinical Research (rcdc), Brain Disorders (rcdc), Comparative Effectiveness Research (rcdc), Clinical Trials and Supportive Activities (rcdc), Neurosciences (rcdc), Orphan Drug (rcdc), 6.1 Pharmaceuticals (hrcs-rac), Cancer (hrcs-hc), Humans (mesh), Glioblastoma (mesh), Male (mesh), Middle Aged (mesh), Female (mesh), Brain Neoplasms (mesh), Aged (mesh), Lactones (mesh), Adult (mesh), Temozolomide (mesh), Pyrroles (mesh), Survival Rate (mesh), DNA Repair Enzymes (mesh), Follow-Up Studies (mesh), DNA Modification Methylases (mesh), Chemoradiotherapy (mesh), Prognosis (mesh), Antineoplastic Combined Chemotherapy Protocols (mesh), Young Adult (mesh), EORTC 1709, glioma, MGMT, proteasome inhibitor, randomized study, Humans (mesh), Glioblastoma (mesh), Brain Neoplasms (mesh), Lactones (mesh), Pyrroles (mesh), DNA Repair Enzymes (mesh), DNA Modification Methylases (mesh), Antineoplastic Combined Chemotherapy Protocols (mesh), Prognosis (mesh), Survival Rate (mesh), Follow-Up Studies (mesh), Adult (mesh), Aged (mesh), Middle Aged (mesh), Female (mesh), Male (mesh), Young Adult (mesh), Chemoradiotherapy (mesh), Temozolomide (mesh), EORTC 1709, MGMT, glioma, proteasome inhibitor, randomized study, Humans (mesh), Glioblastoma (mesh), Male (mesh), Middle Aged (mesh), Female (mesh), Brain Neoplasms (mesh), Aged (mesh), Lactones (mesh), Adult (mesh), Temozolomide (mesh), Pyrroles (mesh), Survival Rate (mesh), DNA Repair Enzymes (mesh), Follow-Up Studies (mesh), DNA Modification Methylases (mesh), Chemoradiotherapy (mesh), Prognosis (mesh), Antineoplastic Combined Chemotherapy Protocols (mesh), Young Adult (mesh), 1109 Neurosciences (for), 1112 Oncology and Carcinogenesis (for), Oncology & Carcinogenesis (science-metrix), 3211 Oncology and carcinogenesis (for-2020)

Popis súboru: application/pdf

Prístupová URL adresa: https://escholarship.org/uc/item/6b7979f3
https://escholarship.org/content/qt6b7979f3/qt6b7979f3.pdf

Visceral fat area and subcutaneous fat area as measures of body composition in soft tissue sarcoma

Autori: Garibay, Eric Robles Cruz, Sylvia M Judge, Sean J a ďalší

Zdroj: Journal of Surgical Oncology. 130(3)

Predmety: 32 Biomedical and Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Cancer (rcdc), Biomedical Imaging (rcdc), Nutrition (rcdc), Obesity (rcdc), Cancer (hrcs-hc), Humans (mesh), Male (mesh), Intra-Abdominal Fat (mesh), Female (mesh), Subcutaneous Fat (mesh), Middle Aged (mesh), Sarcoma (mesh), Body Composition (mesh), Body Mass Index (mesh), Aged (mesh), Retrospective Studies (mesh), Adult (mesh), Survival Rate (mesh), Follow-Up Studies (mesh), Tomography, X-Ray Computed (mesh), Prognosis (mesh), Aged, 80 and over (mesh), body mass index, obesity, soft tissue sarcoma, subcutaneous fat area, visceral fat area, Humans (mesh), Sarcoma (mesh), Tomography, X-Ray Computed (mesh), Body Mass Index (mesh), Prognosis (mesh), Survival Rate (mesh), Retrospective Studies (mesh), Follow-Up Studies (mesh), Body Composition (mesh), Adult (mesh), Aged (mesh), Aged, 80 and over (mesh), Middle Aged (mesh), Female (mesh), Male (mesh), Subcutaneous Fat (mesh), Intra-Abdominal Fat (mesh), body mass index, obesity, soft tissue sarcoma, subcutaneous fat area, visceral fat area, Humans (mesh), Male (mesh), Intra-Abdominal Fat (mesh), Female (mesh), Subcutaneous Fat (mesh), Middle Aged (mesh), Sarcoma (mesh), Body Composition (mesh), Body Mass Index (mesh), Aged (mesh), Retrospective Studies (mesh), Adult (mesh), Survival Rate (mesh), Follow-Up Studies (mesh), Tomography, X-Ray Computed (mesh), Prognosis (mesh), Aged, 80 and over (mesh), 1112 Oncology and Carcinogenesis (for), Oncology & Carcinogenesis (science-metrix), 3211 Oncology and carcinogenesis (for-2020)

Popis súboru: application/pdf

Prístupová URL adresa: https://escholarship.org/uc/item/3kp4q1v6
https://escholarship.org/content/qt3kp4q1v6/qt3kp4q1v6.pdf

Survival Trends Among Adolescents and Young Adults Diagnosed With Cancer in the United States: Comparisons With Children and Older Adults

Autori: Keegan, Theresa HM Abrahão, Renata Alvarez, Elysia M

Zdroj: Journal of Clinical Oncology. 42(6)

Predmety: 32 Biomedical and Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Rare Diseases (rcdc), Minority Health (rcdc), Pediatric Cancer (rcdc), Cancer (rcdc), Women's Health (rcdc), Clinical Research (rcdc), Health Disparities (rcdc), Aging (rcdc), Pediatric (rcdc), Social Determinants of Health (rcdc), 2.4 Surveillance and distribution (hrcs-rac), 6.1 Pharmaceuticals (hrcs-rac), Cancer (hrcs-hc), Adolescent (mesh), Aged (mesh), Child (mesh), Female (mesh), Humans (mesh), Male (mesh), Young Adult (mesh), Black or African American (mesh), Ethnicity (mesh), Neoplasms (mesh), United States (mesh), Adult (mesh), Racial Groups (mesh), Survival Rate (mesh), Humans (mesh), Neoplasms (mesh), Survival Rate (mesh), Adolescent (mesh), Adult (mesh), Aged (mesh), Child (mesh), United States (mesh), Female (mesh), Male (mesh), Young Adult (mesh), Ethnicity (mesh), Racial Groups (mesh), Black or African American (mesh), Adolescent (mesh), Aged (mesh), Child (mesh), Female (mesh), Humans (mesh), Male (mesh), Young Adult (mesh), Black or African American (mesh), Ethnicity (mesh), Neoplasms (mesh), United States (mesh), Adult (mesh), Racial Groups (mesh), Survival Rate (mesh), 1103 Clinical Sciences (for), 1112 Oncology and Carcinogenesis (for), Oncology & Carcinogenesis (science-metrix), 3211 Oncology and carcinogenesis (for-2020)

Popis súboru: application/pdf

Prístupová URL adresa: https://escholarship.org/uc/item/08t838p9
https://escholarship.org/content/qt08t838p9/qt08t838p9.pdf

TTF-1 negativity in synchronous M1b/M1c wildtype lung adenocarcinoma brain metastases predicts worse survival with increased risk of intracranial progression

Autori: Wasilewski, David Araceli, Tommaso Bischoff, Philip a ďalší

Zdroj: J Neurooncol

Predmety: 0301 basic medicine, 03 medical and health sciences, 0302 clinical medicine, Research, Disease Progression [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], TTF-1, Adenocarcinoma of Lung/surgery [MeSH], Survival, Male [MeSH], Brain Neoplasms/mortality [MeSH], Brain Metastasis, Ki67, Edema volume, LUAD, Female [MeSH], Lung Neoplasms/mortality [MeSH], Follow-Up Studies [MeSH], Brain Neoplasms/secondary [MeSH], Adult [MeSH], Humans [MeSH], Tumor volume, Retrospective Studies [MeSH], Middle Aged [MeSH], Adenocarcinoma of Lung/metabolism [MeSH], Survival Rate [MeSH], Biomarkers, Tumor/metabolism [MeSH], Adenocarcinoma of Lung/mortality [MeSH], Prognosis [MeSH], Lung Neoplasms/pathology [MeSH], Lung Neoplasms/metabolism [MeSH], Adenocarcinoma of Lung/pathology [MeSH], Brain Neoplasms/metabolism [MeSH], Thyroid Nuclear Factor 1/metabolism [MeSH]

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39630375
https://repository.publisso.de/resource/frl:6499899

Multimodal treatment of glioblastoma with multiple lesions - a multi-center retrospective analysis

Autori: Harald Krenzlin Dragan Jankovic Alice Dauth a ďalší

Prispievatelia: Harald Krenzlin Dragan Jankovic Alice Dauth a ďalší

Zdroj: J Neurooncol

Predmety: Male, Adult, Brain Neoplasms, Research, 610 Medizin, Female [MeSH], Follow-Up Studies [MeSH], Aged [MeSH], Adult [MeSH], Humans [MeSH], Multimodal therapy, Retrospective Studies [MeSH], Middle Aged [MeSH], Glioblastoma/pathology [MeSH], Glioblastoma, Glioblastoma/therapy [MeSH], Neurosurgical Procedures [MeSH], Extent of resection, Survival Rate [MeSH], Multicentric, Glioblastoma/mortality [MeSH], Male [MeSH], Prognosis [MeSH], Brain Neoplasms/mortality [MeSH], Multifocal, Combined Modality Therapy [MeSH], Brain Neoplasms/pathology [MeSH], Brain Neoplasms/therapy [MeSH], Middle Aged, Prognosis, Combined Modality Therapy, Neurosurgical Procedures, ddc, Survival Rate, 03 medical and health sciences, 0302 clinical medicine, 610 Medical sciences, Humans, Female, Retrospective Studies, Aged, Follow-Up Studies

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39560695
https://repository.publisso.de/resource/frl:6501576
https://mediatum.ub.tum.de/doc/1770657/document.pdf

A multi-center, clinical analysis of IDH-mutant gliomas, WHO Grade 4: implications for prognosis and clinical trial design

Autori: Wetzel, Ethan A. Nohman, Amin I. Hsieh, Annie L. a ďalší

Zdroj: J Neurooncol

Predmety: Male, Adult, Clinical Trials as Topic, Brain Neoplasms, Research, Glioma, Neoplasm Grading [MeSH], Aged [MeSH], Research Design [MeSH], Glioma/mortality [MeSH], Glioma/pathology [MeSH], Male [MeSH], Astrocytoma/genetics [MeSH], Brain Neoplasms/mortality [MeSH], Cyclin-Dependent Kinase Inhibitor p15/genetics [MeSH], Astrocytoma, Astrocytoma/mortality [MeSH], Female [MeSH], Follow-Up Studies [MeSH], Mutation [MeSH], Brain Neoplasms/genetics [MeSH], Adult [MeSH], Humans [MeSH], Astrocytoma/pathology [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Isocitrate dehydrogenase (IDH), Cyclin-Dependent Kinase Inhibitor p16/genetics [MeSH], Survival Rate [MeSH], Glioma/diagnosis [MeSH], Clinical Trials as Topic [MeSH], Biomarkers, Tumor/genetics [MeSH], Glioma/genetics [MeSH], Prognosis [MeSH], Young Adult [MeSH], WHO grade 4, Isocitrate Dehydrogenase/genetics [MeSH], Brain Neoplasms/pathology [MeSH], Middle Aged, Prognosis, Isocitrate Dehydrogenase, Survival Rate, Research Design, Mutation, Humans, Female, Neoplasm Grading, Cyclin-Dependent Kinase Inhibitor p16, Retrospective Studies, Aged, Cyclin-Dependent Kinase Inhibitor p15, Follow-Up Studies

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39432026
https://repository.publisso.de/resource/frl:6495852

Neoadjuvant chemoradiotherapy in combination with deep regional hyperthermia followed by surgery for rectal cancer: a systematic review and meta-analysis: a systematic review and meta-analysis

Autori: Ademaj, Adela Stieb, Sonja Gani, Cihan a ďalší

Zdroj: Strahlenther Onkol
Strahlentherapie und Onkologie

Predmety: Locally recurrent rectal cancer, Original Article, Chemoradiotherapy, Chemoradiotherapy, Adjuvant [MeSH], Rectal Neoplasms/mortality [MeSH], Hyperthermia, Induced/mortality [MeSH], Humans [MeSH], Treatment Outcome [MeSH], Locally advanced rectal cancer, Neoadjuvant Therapy/methods [MeSH], Survival Rate [MeSH], Rectal Neoplasms/therapy [MeSH], Hyperthermia, Induced/methods [MeSH], Disease-Free Survival [MeSH], Rectal Neoplasms/pathology [MeSH], Deep regional hyperthermia, Combined Modality Therapy [MeSH], Neoplasm Recurrence, Local/therapy [MeSH], Chemoradiotherapy [MeSH], Neoplasm Recurrence, Local/mortality [MeSH]

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39419904
https://repository.publisso.de/resource/frl:6493882

Perioperative Complications and In-Hospital Mortality in Paraplegic Radical Cystectomy Patients

Autori: Di Bello, Francesco Siech, Carolin de Angelis, Mario a ďalší

Zdroj: Ann Surg Oncol

Predmety: Male, Paraplegia, Bladder, ICU, Morbidity, NIS, Surgery, Urinary Bladder Neoplasms/complications [MeSH], Aged [MeSH], Postoperative Complications/mortality [MeSH], Risk Factors [MeSH], Hospital Mortality [MeSH], Urinary Bladder Neoplasms/surgery [MeSH], Male [MeSH], Intraoperative Complications/mortality [MeSH], Postoperative Complications/etiology [MeSH], Paraplegia/mortality [MeSH], Female [MeSH], Follow-Up Studies [MeSH], Humans [MeSH], Retrospective Studies [MeSH], Urinary Bladder Neoplasms/mortality [MeSH], Cystectomy/adverse effects [MeSH], Middle Aged [MeSH], Urinary Bladder Neoplasms/pathology [MeSH], Paraplegia/etiology [MeSH], Survival Rate [MeSH], Urologic Oncology, Prognosis [MeSH], Cystectomy/mortality [MeSH], Middle Aged, Cystectomy, Prognosis, Survival Rate, Postoperative Complications, Urinary Bladder Neoplasms, Risk Factors, Humans, Female, Hospital Mortality, Intraoperative Complications, Aged, Follow-Up Studies, Retrospective Studies

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39377845
https://hdl.handle.net/11588/982706
https://hdl.handle.net/11380/1366929
https://doi.org/10.1245/s10434-024-16332-3
https://repository.publisso.de/resource/frl:6522422

LocoMMotion: a study of real-life current standards of care in triple-class exposed patients with relapsed/refractory multiple myeloma – 2-year follow-up (final analysis): a study of real-life current standards of care in triple-class exposed patients with relapsed/refractory multiple myeloma – 2-year follow-up (final analysis)

Autori: María-Victoria Mateos Katja Weisel Valerio De Stefano a ďalší

Prispievatelia: María-Victoria Mateos Katja Weisel Valerio De Stefano a ďalší

Zdroj: Leukemia

Predmety: Male, Adult, Immunology, Female [MeSH], 692/308/2779/109, Follow-Up Studies [MeSH], Aged, 80 and over [MeSH], Multiple Myeloma/pathology [MeSH], Aged [MeSH], Adult [MeSH], Humans [MeSH], Prospective Studies [MeSH], Middle Aged [MeSH], Neoplasm Recurrence, Local/pathology [MeSH], 692/699/67/1059, Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Survival Rate [MeSH], Article, Male [MeSH], Standard of Care [MeSH], Prognosis [MeSH], Multiple Myeloma/mortality [MeSH], Multiple Myeloma/therapy [MeSH], Multiple Myeloma/drug therapy [MeSH], Neoplasm Recurrence, Local/drug therapy [MeSH], article, Drug Resistance, Neoplasm [MeSH], 3211 Oncology and carcinogenesis, Antineoplastic Combined Chemotherapy Protocols, Humans, 1112 Oncology and Carcinogenesis, Prospective Studies, Aged, Aged, 80 and over, OUTCOMES, Science & Technology, 3202 Clinical sciences, 1103 Clinical Sciences, Standard of Care, Hematology, Middle Aged, Prognosis, [SDV] Life Sciences [q-bio], Survival Rate, Oncology, ANTIBODY, Drug Resistance, Neoplasm, Female, Neoplasm Recurrence, Local, 3201 Cardiovascular medicine and haematology, Multiple Myeloma, Life Sciences & Biomedicine, Follow-Up Studies

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39322709
https://pure.amsterdamumc.nl/en/publications/e814ec41-946c-4b67-a7b5-ce520085f64f
https://doi.org/10.1038/s41375-024-02404-6
https://lirias.kuleuven.be/handle/20.500.12942/768901
https://doi.org/10.1038/s41375-024-02404-6
https://repository.publisso.de/resource/frl:6518595
https://nantes-universite.hal.science/hal-05095631v1
https://nantes-universite.hal.science/hal-05095631v1/document
https://doi.org/10.1038/s41375-024-02404-6

Determinants of long-term survival in patients with IDH-mutant gliomas

Autori: Katzendobler, Sophie Niedermeyer, Sebastian Blobner, Jens a ďalší

Prispievatelia: Katzendobler, Sophie Niedermeyer, Sebastian Blobner, Jens a ďalší

Zdroj: J Neurooncol

Predmety: Male, Adult, Adolescent, Oligodendroglioma, 610 Medicine & health, Aged [MeSH], Glioma/mortality [MeSH], Glioma/pathology [MeSH], Male [MeSH], Astrocytoma/genetics [MeSH], Brain Neoplasms/mortality [MeSH], Case-Control Studies [MeSH], Astrocytoma, Astrocytoma/mortality [MeSH], Adolescent [MeSH], Female [MeSH], Oligodendroglioma/mortality [MeSH], Follow-Up Studies [MeSH], Mutation [MeSH], Brain Neoplasms/genetics [MeSH], Adult [MeSH], Humans [MeSH], Astrocytoma/pathology [MeSH], Oligodendroglioma/pathology [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], IDH-mutation, Oligodendroglioma/genetics [MeSH], Survival Rate [MeSH], Lower grade glioma, Research, Glioma/genetics [MeSH], Prognosis [MeSH], Young Adult [MeSH], Chemotherapy, Temozolomide, Radiotherapy, Isocitrate Dehydrogenase/genetics [MeSH], Brain Neoplasms/pathology [MeSH], Young Adult, Humans, 1306 Cancer Research, Retrospective Studies, Aged, Brain Neoplasms, Glioma, Middle Aged, Prognosis, Isocitrate Dehydrogenase, 10040 Clinic for Neurology, Survival Rate, 2728 Neurology (clinical), 2808 Neurology, Case-Control Studies, Mutation, 2730 Oncology, Female, Follow-Up Studies

Popis súboru: s11060_024_04826_9.pdf - application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39316316
https://repository.publisso.de/resource/frl:6490810
https://epub.ub.uni-muenchen.de/126248/

Adult Prostate Sarcoma: Demographics, Treatment Patterns, and Survival

Autori: Siech C. de Angelis M. Di Bello F. a ďalší

Zdroj: Ann Surg Oncol

Predmety: Male, Adult, Leiomyosarcoma, Prostatectomy, Prostatic Neoplasms, Sarcoma, Middle Aged, Prognosis, Cancer-specific mortality, Mesenchymal tumor, Prostate cancer, SEER, Variant histology, Combined Modality Therapy, Survival Rate, Rhabdomyosarcoma, Humans, Original Article, Aged [MeSH], Prostatic Neoplasms/mortality [MeSH], Prostatic Neoplasms/pathology [MeSH], Sarcoma/mortality [MeSH], Leiomyosarcoma/therapy [MeSH], Male [MeSH], Sarcoma/therapy [MeSH], Combined Modality Therapy [MeSH], Follow-Up Studies [MeSH], Leiomyosarcoma/mortality [MeSH], SEER Program [MeSH], Adult [MeSH], Humans [MeSH], Leiomyosarcoma/pathology [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Survival Rate [MeSH], Sarcoma/pathology [MeSH], Prostatectomy/mortality [MeSH], Rhabdomyosarcoma/therapy [MeSH], Prognosis [MeSH], Prostatic Neoplasms/therapy [MeSH], Rhabdomyosarcoma/mortality [MeSH], Rhabdomyosarcoma/pathology [MeSH], SEER Program, Aged, Follow-Up Studies, Retrospective Studies

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39313727
https://repository.publisso.de/resource/frl:6505635

Reduced Intensity transplantation vs chemotherapy in CR1. A prospective, pseudorandomized study in 50–70 year old AML patients

Autori: Mats Brune Thomas Kiss Harald Anderson a ďalší

Zdroj: Bone Marrow Transplant

Predmety: Male, Transplantation Conditioning, Kirurgi, 692/699/1541/1990/283/1897, Female [MeSH], Transplantation Conditioning/methods [MeSH], Aged [MeSH], Humans [MeSH], Prospective Studies [MeSH], Leukemia, Myeloid, Acute/mortality [MeSH], Middle Aged [MeSH], Survival Rate [MeSH], Article, Male [MeSH], 692/700/565/2319, Hematopoietic Stem Cell Transplantation/methods [MeSH], Leukemia, Myeloid, Acute/therapy [MeSH], article, Hematopoietic Stem Cell Transplantation, Hematology, Middle Aged, Survival Rate, Leukemia, Myeloid, Acute, Humans, Surgery, Female, Hematologi, Prospective Studies, Aged

Popis súboru: application/pdf; pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39223244
https://repository.publisso.de/resource/frl:6521115
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-555190

Survival After Transarterial Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: An Updated Meta-analysis and Meta-regression

Autori: Cocozza M. A. Dajti E. Braccischi L. a ďalší

Zdroj: Cardiovasc Intervent Radiol

Predmety: Cholangiocarcinoma, Meta-analysis, Meta-regression, Radioembolization, Selective internal radiation therapy, Survival Rate, 03 medical and health sciences, 0302 clinical medicine, Bile Duct Neoplasms, Humans, Scientific Paper (Other), Embolization, Therapeutic, Bile Duct Neoplasms/mortality [MeSH], Humans [MeSH], Embolization, Therapeutic/methods [MeSH], Cholangiocarcinoma/therapy [MeSH], Cholangiocarcinoma/mortality [MeSH], Survival Rate [MeSH], Bile Duct Neoplasms/therapy [MeSH], Interventional Oncology

Popis súboru: application/pdf; application/vnd.openxmlformats-officedocument.wordprocessingml.document; pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39187651
https://repository.publisso.de/resource/frl:6515123
https://hdl.handle.net/11585/1003265
https://link.springer.com/article/10.1007/s00270-024-03825-7
https://doi.org/10.1007/s00270-024-03825-7

Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group

Autori: Anne Mea Spanjaart Per Ljungman Gloria Tridello a ďalší

Prispievatelia: Anne Mea Spanjaart Per Ljungman Gloria Tridello a ďalší

Zdroj: Leukemia
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)

Predmety: Male, Cancer Research, [SDV]Life Sciences [q-bio], COVID-19 (Malaltia) - Mortalitat, Immunotherapy, Adoptive, DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::inmunomodulación::inmunoterapia::inmunización::inmunización pasiva::transferencia adoptiva::inmunoterapia adoptiva, Child, Receptors, Chimeric Antigen, COVID-19, COVID-19/immunology [MeSH], Aged [MeSH], Receptors, Chimeric Antigen/immunology [MeSH], COVID-19/therapy [MeSH], COVID-19/mortality [MeSH], Male [MeSH], SARS-CoV-2/immunology [MeSH], Child [MeSH], Hematologic Neoplasms/mortality [MeSH], Adolescent [MeSH], Female [MeSH], Immunotherapy, Adoptive/adverse effects [MeSH], Adult [MeSH], Humans [MeSH], Treatment Outcome [MeSH], Middle Aged [MeSH], Europe/epidemiology [MeSH], Survival Rate [MeSH], Article, Hematologic Neoplasms/therapy [MeSH], Young Adult [MeSH], 631/250/251, 631/67/1990, Hematologic Neoplasms/immunology [MeSH], Immunotherapy, Adoptive/methods [MeSH], article, Child, Preschool [MeSH], Sang - Malalties - Immunoteràpia, Hematology, Middle Aged, 3. Good health, [SDV] Life Sciences [q-bio], Europe, Survival Rate, Otros calificadores::Otros calificadores::/terapia, Treatment Outcome, Oncology, Hematologic Neoplasms, Child, Preschool, VACCINATION, Female, 3201 Cardiovascular medicine and haematology, Life Sciences & Biomedicine, Adult, Adolescent, Immunology, Other subheadings::Other subheadings::/therapy, SARS-COV-2, Young Adult, SDG 3 - Good Health and Well-being, 3211 Oncology and carcinogenesis, DISEASES::Neoplasms::Neoplasms by Site::Hematologic Neoplasms, Humans, 1112 Oncology and Carcinogenesis, ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus, Aged, Other subheadings::Other subheadings::Other subheadings::Other subheadings::/mortality, Science & Technology, SARS-CoV-2, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis::Treatment Outcome, 3202 Clinical sciences, 1103 Clinical Sciences, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy::Immunization::Immunization, Passive::Adoptive Transfer::Immunotherapy, Adoptive, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamiento, Otros calificadores::Otros calificadores::Otros calificadores::Otros calificadores::/mortalidad, Avaluació de resultats (Assistència sanitària), ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias hematológicas

Popis súboru: application/pdf; pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39043963
https://hdl.handle.net/11351/12651
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=15097
https://dspace.library.uu.nl/handle/1874/455493
https://pure.amsterdamumc.nl/en/publications/b1e47daf-4a42-4db4-a824-b8b34f6c134e
https://doi.org/10.1038/s41375-024-02336-1
https://lirias.kuleuven.be/handle/20.500.12942/752756
https://doi.org/10.1038/s41375-024-02336-1
https://hal.science/hal-04921717v1
https://doi.org/10.1038/s41375-024-02336-1
https://repository.publisso.de/resource/frl:6519899

Prognostic Relevance of the Proximal Resection Margin Distance in Distal Gastrectomy for Gastric Adenocarcinoma

Autori: Rompen, Ingmar F. Schütte, Isabel Crnovrsanin, Nerma a ďalší

Zdroj: Ann Surg Oncol

Predmety: Male, Gastrointestinal Oncology, Margins of Excision, Adenocarcinoma, Middle Aged, Prognosis, Survival Rate, 03 medical and health sciences, 0302 clinical medicine, Gastrectomy/mortality [MeSH], Aged [MeSH], Stomach Neoplasms/pathology [MeSH], Margins of Excision [MeSH], Stomach Neoplasms/surgery [MeSH], Resection margin, Neoplasm Recurrence, Local/pathology [MeSH], Stomach Neoplasms/mortality [MeSH], Neoplasm Recurrence, Local/surgery [MeSH], Male [MeSH], Adenocarcinoma/pathology [MeSH], Surgery, Gastrectomy/methods [MeSH], Gastric cancer, Female [MeSH], Follow-Up Studies [MeSH], Humans [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Survival Rate [MeSH], Prognosis [MeSH], Gastric neoplasm, Margin distance, Adenocarcinoma/mortality [MeSH], Adenocarcinoma/surgery [MeSH], Distal gastrectomy, Stomach Neoplasms, Gastrectomy, Humans, Female, Neoplasm Recurrence, Local, Aged, Follow-Up Studies, Retrospective Studies

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38969858
https://repository.publisso.de/resource/frl:6495707